Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study. (2024). Dermatology Practical & Conceptual, 14(4), e2024250. https://doi.org/10.5826/dpc.1404a250